Brokerages Set Omega Healthcare Investors, Inc. (NYSE:OHI) Price Target at $46.63

Shares of Omega Healthcare Investors, Inc. (NYSE:OHI) have earned a consensus rating of “Moderate Buy” from the twelve research firms that are currently covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $46.4444.

OHI has been the subject of several research reports. Scotiabank raised their target price on Omega Healthcare Investors from $42.00 to $45.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 13th. Weiss Ratings restated a “buy (b)” rating on shares of Omega Healthcare Investors in a research note on Wednesday, October 8th. Citigroup reaffirmed a “buy” rating and set a $50.00 price objective (up from $45.00) on shares of Omega Healthcare Investors in a report on Wednesday, November 12th. Cantor Fitzgerald assumed coverage on shares of Omega Healthcare Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $50.00 target price on the stock. Finally, Mizuho increased their price target on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a research report on Thursday, September 11th.

Omega Healthcare Investors Trading Up 0.1%

Shares of OHI stock opened at $44.54 on Friday. The firm has a market capitalization of $13.16 billion, a P/E ratio of 24.88, a price-to-earnings-growth ratio of 1.98 and a beta of 0.56. Omega Healthcare Investors has a 1 year low of $35.04 and a 1 year high of $46.36. The firm’s fifty day simple moving average is $43.23 and its 200 day simple moving average is $40.87. The company has a current ratio of 7.11, a quick ratio of 7.11 and a debt-to-equity ratio of 0.95.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.77 by $0.02. Omega Healthcare Investors had a net margin of 46.83% and a return on equity of 10.72%. The company had revenue of $311.59 million for the quarter, compared to analyst estimates of $262.48 million. During the same period last year, the business posted $0.71 EPS. The business’s quarterly revenue was up 14.4% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. As a group, sell-side analysts predict that Omega Healthcare Investors will post 2.86 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, November 17th. Investors of record on Monday, November 3rd were given a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 6.0%. The ex-dividend date was Monday, November 3rd. Omega Healthcare Investors’s dividend payout ratio (DPR) is 149.72%.

Insiders Place Their Bets

In other news, CEO C Taylor Pickett purchased 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The stock was purchased at an average cost of $43.14 per share, with a total value of $862,800.00. Following the acquisition, the chief executive officer directly owned 20,000 shares of the company’s stock, valued at approximately $862,800. This trade represents a ? increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CIO Vikas Gupta acquired 11,500 shares of the firm’s stock in a transaction on Thursday, November 6th. The shares were purchased at an average cost of $42.97 per share, for a total transaction of $494,155.00. Following the completion of the purchase, the executive directly owned 13,773 shares of the company’s stock, valued at approximately $591,825.81. The trade was a 505.94% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of OHI. Caitong International Asset Management Co. Ltd bought a new stake in Omega Healthcare Investors during the 2nd quarter worth approximately $26,000. Salem Investment Counselors Inc. acquired a new position in Omega Healthcare Investors in the third quarter worth $39,000. Smartleaf Asset Management LLC grew its holdings in shares of Omega Healthcare Investors by 40.9% during the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock worth $34,000 after purchasing an additional 268 shares during the last quarter. CENTRAL TRUST Co increased its stake in shares of Omega Healthcare Investors by 1,654.4% in the second quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust’s stock valued at $37,000 after buying an additional 943 shares in the last quarter. Finally, True Wealth Design LLC raised its holdings in shares of Omega Healthcare Investors by 273.5% in the third quarter. True Wealth Design LLC now owns 1,113 shares of the real estate investment trust’s stock valued at $47,000 after buying an additional 815 shares during the last quarter. Institutional investors own 65.25% of the company’s stock.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.